Ebola disease. As the world watches with increasing horror the slow but sure spread of this killer, health authorities are struggling with how best to treat the afflicted while maintaining strict isolation and quarantine.
Distressingly, many physicians, nurses, and other healthcare workers taking care of ill Ebola disease patients have themselves been infected and are in mortal danger, including Americans Dr. Kent Brantly and Nancy Writebol, aid workers for the charity Samaritan’s Purse.
The Ebola disease is highly infectious, meaning once a patient comes in contact with even a few virus organisms, a severe illness almost always develops. Patients commonly develop fatal hemorrhages from their mouths, eyes, and skin. Organ failure including the heart, lungs, liver, and kidney systems is invariably occurs
There is no vaccine for Ebola currently and no specific pharmaceutical cure or antidote other than supportive care such as intravenous fluids, oxygen, blood transfusions, and correcting electrolyte abnormalities.
Despite this, news organizations today are reporting the importation of an untried experimental serum intended for the American patients to try to halt or reverse the course of the disease, with health authorities no doubt willing to risk any unknown adverse side effects against a hoped for, life-saving benefit.
However, sadly there was apparently only enough medicine for one dose, which Dr. Brantly gallantly gave to Ms. Writebol. Â As of this writing, both Americans remain in grave condition and are to be transferred to the United States for care.
In this clearly desperate scenario for those currently infected with Ebola diseaseÂ and for the worldwide health ramifications, would it be wise to ask what other unproven (even “kitchen sink”) experimental treatments might be employed as a last gasp strategy to try to save lives when there is nothing left to do?
One possibility that might bear consideration is Rife therapy – a controversial treatment modality that has been largely discredited by medical authorities in the United States as unproven (but not specifically dangerous.)
A large measure of the condemnation by US officials resulted because of claims in the 1980s that the treatment was effective for the treatment of cancer.
Today, although considered little better than quackery at best by some and treated with howls of derision by others in the American medical establishment, Rife therapy is a more widely accepted therapeutic modality in Europe and is used for a wide variety of conditions, including cancer and other serious illness.
Rife therapy machines come in many styles and models. For illustration purposes in this discussion, one popular and commonly used machine sold internationally is described as a photon resonant light emission device.
The device (about the size of a small suitcase) is a non-contact, non-invasive device that uses electricity to stimulate argon gas in a closed tube to emit an electrostatic charge, light, and an electromagnetic frequency (EMF.)
When the device is turned on it delivers radio frequencies in a 360 degree pattern. Literature from the manufacturer states that the resultant EMF can be used for the control of microbes, including viruses, bacteria, fungi, and yeast*.
The manufacturer states in the instruction manual that the anti-microbe EMFs travel up to 30 feet and will penetrate walls, concrete, steel, and lead.
The device is easily programmable to deliver the specific frequencies desired. There are published protocols widely available on the Internet on specific frequency protocols that purportedly are effective for different classes of microbes being targeted.
Almost all state medical boards in the United States strongly discourage physician participation or recommendation of Rife treatment. Penalties for prescribing Rife treatment can include censure and loss of licensure.
Despite this official condemnation, Rife machines can be purchased on the internet and are quietly used by tens of thousands of patients in the United States for a wide range of ills, including most commonly as an antimicrobial strategy for Lyme disease. Many of these patients give positive anecdotal reports of efficacy in controlling their infections.
Not surprisingly, due to antipathy of the medical establishment most physicians avoid professional consideration of Rife therapy and there are few recent studies investigating Rife therapy in humans.
However, there has been some research in the past 20 years published using animal and in-vitro models that has investigated the use of electromagnetic frequencies as a strategy.
These studies have shown a positive effect in controlling microbial infection and producing beneficial changes in wound healing, immune response, and inflammatory response.
For instance, in a study investigating the use of electromagnetic fields to control the protozoan infection coccidiosis in broiler chickens, it was found that exposure had an antagonistic effect on the causative Eimeria organisms treated birds (Elmusharaf and Cuppen, 2007.)
Also, there are Â suggestions that the use of electromagnetic fields may cause an anti-inflammatory effect and promote wound healing in rats (Jasti and Wetzel, 2001.)
In addition, several studies have suggested in-vitro anti-inflammatory effects of electromagnetic frequency treatment ( Cronstein and Montesinos, 1999; Valbona and Richard, 1999; Montesionos and Yap, 2000.)
EMF exposure has also been shown to effect a heightened immune response in several in-vitro studies (Blank and Khorkova, 1992; Goodman and Blank, 1994; Simco and Mattsson, 2004.)
This EMF mediation of enhanced immunity has also been suggested in a rat model (Mevissen and Haussler, 1998.)
It is generally agreed that containment of the Ebola virus is tantamount and is likely to be done efficiently in more developed and and resourced medical systems.
However, containment in the West African Ebola treatment systems is likely to remain problematic. Incomplete eradication will permit the possibility of continual “seeding” of cases in Europe, Asia, and the US.
Any improvement in the length of the clinical course or lessening of symptom severity would likely promote containment efforts.
It is no doubt easier to contain and control transmission of Ebola Â in less ill patients who can handle their own secretions than in many more patients on ventilators, with central lines, who are hemorrhaging, etc.
So, how could Rife therapy actually be employed in a treatment facility caring for Ebola patients?
InsideSurgery.com interviewed one US-based physician who quietly helps set up Rife protocols for his patients. Understandably, he did not want to be identified to avoid regulatory repercussions. The following is based on the discussion with this editor.
One scenario he described could have the relatively inexpensive Rife machine set up outside of the isolation tent to avoid contamination of the Rife equipment. The unit and the control pad could be wrapped in clear plastic as an added precaution without affecting the performance or treatment effect.
The desired frequencies could then be programmed. As Rife has never been used on Ebola patients and there is no published anecdotal or research data, initial treatment frequencies could include several from the 50 or “viral complex” frequencies empirically used by patients.**
Alternately, frequencies surmised by some to be effective against viral organism entry into host cells could be attempted.***
Once the machine is turned on the unit does not have to be monitored while it is operating.
The patients to be treated would remain in their hospital beds or perhaps moved to within 6-12 feet of the device for optimal effect while still remaining on the isolation side of the structure. Depending on the size of the isolation room, multiple patients could be treated simultaneously.
The timing and duration of the treatment sessions could be tailored based on clinical response. Patients with other serious viral illnesses typically use the machine once or twice a day.
But, in the end, the harsh, horrible truth is that there is no more serious and deadly viral illness than Ebola. In the not too distant future, likely spurred on by this outbreak, scientists will design and mass produce a vaccine to spare the world this scourge.
But, sadly, that welcome development will come too late for those that are ill and dying today. Do we as physicians, health care providers, and fellow human beings owe it to those afflicted and in agony to at least be open and willing to consider an unproven, untested, “kitchen sink”, people-dying-gotta-try-everything treatment that might get them to the other side of this terrible disease?
They are counting on us.
* The manufacture includes a disclaimer in their sales and product literature that the PERL is not intended as a medical device.
** “Viral complex” Rife frequencies used empirally by patients – 10000, 7344, 5000, 2950, 2900, 2650, 2600, 1550, 1234, 430, 620, 624, 646, 866, 5148, 2213, 1918, 742.4, 303, 23.2, 20, 864, 790, 690, 610, 470, 484, 986, 644, 254, 30, 33, 6000, 599, 611, 613, 2127, 2080, 2050, 2013, 2008, 2003, 2000, 1850, 880, 803, 800, 787, 727, 660, 484, 465, 440, 35, 500, 200, 68
*** Postulated hemorrhagic viral Rife frequencies – 0.03, 0.12, 0.95, 2.50, 22.50, 51.33, 193.50, 356. 72